149 related articles for article (PubMed ID: 35037241)
1. Risk of malignancy in patients with inflammatory bowel disease: A population-based cohort study from China.
Zhang H; Zhang M; Chen X; Guo M; Zhou R; Lv H; Li Y; Tan B; Li J; Xu H; Zheng W; Yang H; Qian J
Int J Cancer; 2022 Jun; 150(11):1770-1778. PubMed ID: 35037241
[TBL] [Abstract][Full Text] [Related]
2. Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation.
Kappelman MD; Farkas DK; Long MD; Erichsen R; Sandler RS; Sørensen HT; Baron JA
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):265-73.e1. PubMed ID: 23602821
[TBL] [Abstract][Full Text] [Related]
3. Cancer Risk in 2621 Chinese Patients with Inflammatory Bowel Disease: A Population-based Cohort Study.
So J; Tang W; Leung WK; Li M; Lo FH; Wong MTL; Sze ASF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Lam TY; Lam V; Lee TW; Lo HHH; Tang CM; Wong CL; Wu JCY; Chan FKL; Sung JJY; Harbord M; Ng SC
Inflamm Bowel Dis; 2017 Nov; 23(11):2061-2068. PubMed ID: 28991855
[TBL] [Abstract][Full Text] [Related]
4. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
[TBL] [Abstract][Full Text] [Related]
5. Higher Risk for Hematological Malignancies in Inflammatory Bowel Disease: A Nationwide Population-based Study in Taiwan.
Wang LH; Yang YJ; Cheng WC; Wang WM; Lin SH; Shieh CC
Am J Gastroenterol; 2016 Sep; 111(9):1313-9. PubMed ID: 27296944
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory Bowel Disease and Long-term Risk of Cancer: A Prospective Cohort Study Among Half a Million Adults in UK Biobank.
Wu S; Xie S; Yuan C; Yang Z; Liu S; Zhang Q; Sun F; Wu J; Zhan S; Zhu S; Zhang S
Inflamm Bowel Dis; 2023 Mar; 29(3):384-395. PubMed ID: 35639937
[TBL] [Abstract][Full Text] [Related]
7. Risk of intestinal and extra-intestinal cancers in patients with inflammatory bowel diseases: A population-based cohort study in northeastern Italy.
Taborelli M; Sozzi M; Del Zotto S; Toffolutti F; Montico M; Zanier L; Serraino D
PLoS One; 2020; 15(6):e0235142. PubMed ID: 32574216
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory Bowel Diseases Increase Risk of Type 2 Diabetes in a Nationwide Cohort Study.
Jess T; Jensen BW; Andersson M; Villumsen M; Allin KH
Clin Gastroenterol Hepatol; 2020 Apr; 18(4):881-888.e1. PubMed ID: 31394285
[TBL] [Abstract][Full Text] [Related]
9. Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study.
Jess T; Horváth-Puhó E; Fallingborg J; Rasmussen HH; Jacobsen BA
Am J Gastroenterol; 2013 Dec; 108(12):1869-76. PubMed ID: 23978954
[TBL] [Abstract][Full Text] [Related]
10. The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea.
Lee HS; Park SH; Yang SK; Ye BD; Kim JH; Kim SO; Soh JS; Lee S; Bae JH; Lee HJ; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
Scand J Gastroenterol; 2015 Feb; 50(2):188-96. PubMed ID: 25515241
[TBL] [Abstract][Full Text] [Related]
11. Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study.
Biancone L; Armuzzi A; Scribano ML; Castiglione F; D'Incà R; Orlando A; Papi C; Daperno M; Vecchi M; Riegler G; Fries W; Alvisi P; Meucci G; Mocciaro F; Rogai F; Festa S; Guidi L; Testa A; Spina L; Renna S; Viola A; Patturelli M; Di Mitri R; Frankovic I; Calabrese E; Petruzziello C; De Cristofaro E; Sena G; Ruffa A; Neri B; Rossi A
Inflamm Bowel Dis; 2020 Feb; 26(3):450-459. PubMed ID: 31498388
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory bowel disease and risk of adenocarcinoma and neuroendocrine tumors in the small bowel.
Yu J; Refsum E; Perrin V; Helsingen LM; Wieszczy P; Løberg M; Bretthauer M; Adami HO; Ye W; Blom J; Kalager M
Ann Oncol; 2022 Jun; 33(6):649-656. PubMed ID: 35276334
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory bowel disease and cervical neoplasia: a population-based nationwide cohort study.
Rungoe C; Simonsen J; Riis L; Frisch M; Langholz E; Jess T
Clin Gastroenterol Hepatol; 2015 Apr; 13(4):693-700.e1. PubMed ID: 25086189
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory bowel disease and risk of small bowel cancer: a binational population-based cohort study from Denmark and Sweden.
Axelrad JE; Olén O; Sachs MC; Erichsen R; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
Gut; 2021 Feb; 70(2):297-308. PubMed ID: 32474410
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study.
Biancone L; Armuzzi A; Scribano ML; D'Inca R; Castiglione F; Papi C; Angelucci E; Daperno M; Mocciaro F; Riegler G; Fries W; Meucci G; Alvisi P; Spina L; Ardizzone S; Petruzziello C; Ruffa A; Kohn A; Vecchi M; Guidi L; Di Mitri R; Renna S; Emma C; Rogai F; Rossi A; Orlando A; Pallone F;
J Crohns Colitis; 2016 Aug; 10(8):913-24. PubMed ID: 26933032
[TBL] [Abstract][Full Text] [Related]
16. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
Mak JWY; So J; Tang W; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Chan FKL; Ng SC
Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788
[No Abstract] [Full Text] [Related]
17. Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort.
van den Heuvel TR; Wintjens DS; Jeuring SF; Wassink MH; Romberg-Camps MJ; Oostenbrug LE; Sanduleanu S; Hameeteman WH; Zeegers MP; Masclee AA; Jonkers DM; Pierik MJ
Int J Cancer; 2016 Sep; 139(6):1270-80. PubMed ID: 27170593
[TBL] [Abstract][Full Text] [Related]
18. Extracolonic Cancer Risk After Total Colectomy for Inflammatory Bowel Disease: A Population-based Cohort Study.
Mark-Christensen A; Erichsen R; Veres K; Laurberg S; Sørensen HT
J Crohns Colitis; 2020 Jun; 14(5):630-635. PubMed ID: 31811282
[TBL] [Abstract][Full Text] [Related]
19. Treat-to-Target and Regular Surveillance of Inflammatory Bowel Disease Are Associated with Low Incidence and Early-Stage Detection of Malignancies: A Retrospective Cohort Study.
Parigi TL; Allocca M; Furfaro F; D'Amico F; Zilli A; Dal Buono A; Gabbiadini R; Bonovas S; Armuzzi A; Danese S; Fiorino G
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136300
[TBL] [Abstract][Full Text] [Related]
20. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
